Toggle navigation
Menu
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
73°
Search
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Local Weather
News
Sports
Entertainment
Calendar
Games
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Town & Gown
Subscribe
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Odonate Therapeutics Inc
(NQ:
ODT
)
19.35
USD
-1.70 (-8.08%)
Official Closing Price
Updated: 7:54 PM EST, Mar 1, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Odonate Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
Odonate Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020
February 23, 2021
Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced...
From
Business Wire News Releases
Odonate Therapeutics, Inc. (NASDAQ:ODT) Long Term Shareholder Notice: Investigation of Potential Wrongdoing
January 13, 2021
San Diego, CA -- (SBWIRE) -- 01/13/2021 -- Certain directors of Odonate Therapeutics, Inc. are under investigation concerning potential breaches of fiduciary duties.
From
SBWire - Latest Press Releases
Notable Insider Buys Of The Past Week: Danimer Scientific, Cheniere Energy Partners And More
January 02, 2021
Insider buying can be an encouraging signal for potential investors when markets face uncertainty. Insider purchases at a special ...
Tags
IQV
IEP
Kroger
From
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 29, 2020
Gainers Hepion Pharmaceuticals (NASDAQ:HEPA) stock increased by 14.9% to $2.39 during Tuesday's after-market session. At the ...
Tags
MTP
HEPA
General
From
Benzinga
70 Biggest Movers From Thursday
December 28, 2020
Gainers Air T, Inc. (NASDAQ: AIRT) shares jumped 293.6% to close at $38.38 on Thursday after the company announced plans to form a ...
Tags
ENG
BLNK
AVGR
From
Benzinga
Notable Insider Buys In The Week Of Christmas: Foot Locker, GameStop, NetApp And More
December 26, 2020
Insider buying can be an encouraging signal for potential investors when markets face uncertainty. Insider purchases of ...
Tags
Eos Energy Enterprises
CURI
GME
From
Benzinga
42 Stocks Moving In Thursday's Mid-Day Session
December 24, 2020
Gainers Air T, Inc. (NASDAQ: AIRT) gained 85.6% to $18.10 after the company announced plans to form a new aircraft equity vehicle. ...
Tags
Market News
PHAR
ONTX
From
Benzinga
Thinking about buying stock in Gevo Inc, Inovio Pharmaceuticals, Odonate Therapeutics, Cocrystal Pharma, or Vuzix Corp?
December 24, 2020
InvestorsObserver issues critical PriceWatch Alerts for GEVO, INO, ODT, COCP, and VUZI.
From
PR Newswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 24, 2020
Gainers Avinger (NASDAQ:AVGR) shares moved upwards by 98.26% to $0.69 during Thursday's pre-market session. The ...
Tags
TNXP
AVGR
CHEK
From
Benzinga
BeyondSpring Announces the Appointment of Dr. Jeffrey Vacirca to its Board of Directors
December 17, 2020
From
GlobeNewswire News Releases
Noteworthy Friday Option Activity: ODT, ISRG, CYH
December 11, 2020
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Odonate Therapeutics Inc (ODT), where a total volume of 1,924 contracts has been...
Tags
Stocks
From
Market News Video
Positive Results of CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic Breast Cancer, Presented at the 2020 San Antonio Breast Cancer Symposium (SABCS)
December 11, 2020
Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best‑in‑class therapeutics that improve and extend the lives of patients with cancer, today announced...
From
Business Wire News Releases
The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street
December 11, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
FREQ
NMTR
PRTK
From
Benzinga
Odonate Therapeutics Initiates Cohort 3 of CONTESSA TRIO to Evaluate Tesetaxel Monotherapy in Patients with Metastatic Breast Cancer
December 07, 2020
Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced...
From
Business Wire News Releases
The Math Shows IEIH Can Go To $38
December 04, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Odonate Therapeutics to Host Virtual Investor and Analyst Event on December 11, 2020
December 01, 2020
Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced...
From
Business Wire News Releases
ODT Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Odonate Therapeutics, Inc. Shareholders With Losses Exceeding $50K of Class Action and Lead Plaintiff Deadline: November 16, 2020
November 16, 2020
Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Odonate Therapeutics, Inc. ("Odonate" or the "Company") (NASDAQ: ODT) and certain of its...
From
Business Wire News Releases
DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Odonate Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
November 16, 2020
DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Odonate Therapeutics, Inc.
From
Business Wire News Releases
FINAL DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Reminds Odonate Therapeutics, Inc. Investors of Important Monday Deadline in Securities Class Action – ODT
November 15, 2020
From
GlobeNewswire News Releases
ODT FINAL DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Reminds Odonate Therapeutics, Inc. Investors of Important Monday Deadline in Securities Class Action - ODT
November 12, 2020
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Odonate Therapeutics, Inc. (NASDAQ: ODT) between December 7, 2017 and August 21, 2020, inclusive (the "Class...
From
PR Newswire
SHAREHOLDER DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Odonate Therapeutics, Inc.– ODT; IMPORTANT NOV. 16 DEADLINE- ODT
November 12, 2020
From
GlobeNewswire News Releases
ODT STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against Odonate Therapeutics, Inc. – ODT
November 11, 2020
From
GlobeNewswire News Releases
NASDAQ:ODT Shareholder Notice: Deadline on November 16, 2020 in Lawsuit Against Odonate Therapeutics, Inc.
November 11, 2020
San Diego, CA -- (SBWIRE) -- 11/11/2020 -- A deadline is coming up on November 16, 2020 in the lawsuit filed for certain investors of Odonate Therapeutics, Inc. (NASDAQ:ODT) over alleged securities...
From
SBWire - Latest Press Releases
ODT, NNOX & GOCO Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions
November 11, 2020
From
GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Odonate Therapeutics, Inc. and of Class Action Lawsuit and Upcoming Deadline – ODT
November 08, 2020
From
GlobeNewswire News Releases
ROSEN, NATIONAL TRIAL LAWYERS, Reminds Odonate Therapeutics, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm –
November 06, 2020
From
GlobeNewswire News Releases
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Reminds Odonate Therapeutics, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K
November 04, 2020
From
GlobeNewswire News Releases
ODT, NNOX & GOCO Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Upcoming Lead Plaintiff Deadlines
November 03, 2020
From
GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Odonate Therapeutics, Inc. and of Class Action Lawsuit and Upcoming Deadline – ODT
November 02, 2020
From
GlobeNewswire News Releases
Implied IEIH Analyst Target Price: $37
November 02, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.